CYP27B1 and breast carcinoma: Accordingly, the expression of VDR, CYP27B1, and CYP24A1 in breast cancer may favor tumor progression by decreasing the presence of the active 1,25(OH)2D. Nonetheless, it is not known at what concentrations 25(OH)D is protective against breast cancer.